Literature DB >> 25402011

The first familial case of inherited 2q37.3 interstitial deletion with isolated skeletal abnormalities including brachydactyly type E and short stature.

Nolwenn Jean-Marçais1, Matthieu Decamp, Marion Gérard, Virginie Ribault, Joris Andrieux, Marie-Laure Kottler, Ghislaine Plessis.   

Abstract

Albright hereditary osteodystrophy (AHO)-like syndrome is also known as brachydactyly-mental retardation syndrome (BDMR; OMIM 60040). This disorder includes intellectual disability in all patients, skeletal abnormalities, including brachydactyly E (BDE) in approximately half, obesity, and facial dysmorphism. Patients with 2q37 microdeletion or HDAC4 mutation are defined as having an AHO-like phenotype with normal stimulatory G (Gs) function. HDAC4 is involved in neurological, cardiac, and skeletal function. This paper reports the first familial case of 2q37.3 interstitial deletion affecting two genes, HDAC4 and TWIST2. Patients presented with BDE and short stature without intellectual disability, showing that haploinsufficiency of the HDAC4 critical region may lead to a spectrum of phenotypes, ranging from isolated brachydactyly type E to BDMR.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  2q37 deletion; Albright hereditary osteodystrophy-like syndrome; BDMR; HDAC4; brachydactyly; brachydactyly E; intellectual disability

Mesh:

Year:  2014        PMID: 25402011     DOI: 10.1002/ajmg.a.36428

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  Brief psychotic episode in a patient with chromosome 2q37 microdeletion syndrome.

Authors:  Kevin Lally; Nuraini Ibrahim; Mary Kelly; Gautam Gulati
Journal:  BMJ Case Rep       Date:  2017-11-27

2.  Reorganization of inter-chromosomal interactions in the 2q37-deletion syndrome.

Authors:  Philipp G Maass; Anja Weise; Katharina Rittscher; Julia Lichtenwald; A Rasim Barutcu; Thomas Liehr; Atakan Aydin; Yvette Wefeld-Neuenfeld; Laura Pölsler; Sigrid Tinschert; John L Rinn; Friedrich C Luft; Sylvia Bähring
Journal:  EMBO J       Date:  2018-06-19       Impact factor: 11.598

Review 3.  Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.

Authors:  Giovanna Mantovani; Murat Bastepe; David Monk; Luisa de Sanctis; Susanne Thiele; Alessia Usardi; S Faisal Ahmed; Roberto Bufo; Timothée Choplin; Gianpaolo De Filippo; Guillemette Devernois; Thomas Eggermann; Francesca M Elli; Kathleen Freson; Aurora García Ramirez; Emily L Germain-Lee; Lionel Groussin; Neveen Hamdy; Patrick Hanna; Olaf Hiort; Harald Jüppner; Peter Kamenický; Nina Knight; Marie-Laure Kottler; Elvire Le Norcy; Beatriz Lecumberri; Michael A Levine; Outi Mäkitie; Regina Martin; Gabriel Ángel Martos-Moreno; Masanori Minagawa; Philip Murray; Arrate Pereda; Robert Pignolo; Lars Rejnmark; Rebecca Rodado; Anya Rothenbuhler; Vrinda Saraff; Ashley H Shoemaker; Eileen M Shore; Caroline Silve; Serap Turan; Philip Woods; M Carola Zillikens; Guiomar Perez de Nanclares; Agnès Linglart
Journal:  Nat Rev Endocrinol       Date:  2018-08       Impact factor: 43.330

4.  Clinical and genetic analysis in a Chinese cohort of children and adolescents with diabetes/persistent hyperglycemia.

Authors:  Yu Ding; Niu Li; Dan Lou; Qianwen Zhang; Guoying Chang; Juan Li; Xin Li; Qun Li; Xiaodong Huang; Jian Wang; Fan Jiang; Xiumin Wang
Journal:  J Diabetes Investig       Date:  2020-07-23       Impact factor: 4.232

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.